Nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.

One tablet should be dissolved under the tongue or in the buccal pouch at the first sign of an acute anginal attack. The dose may be repeated approximately every 5 minutes, until relief is obtained. If the pain persists after a total of 3 tablets in a 15-minute period, prompt medical attention is recommended. Nitrostat may be used prophylactically 5 to 10 minutes prior to engaging in activities which might precipitate an acute attack.

During administration the patient should rest, preferably in the sitting position.

No dosage adjustment is required in patients with renal failure.

Nitrostat is supplied as white, round, flat-faced tablets in 3 strengths (0.3 mg, 0.4 mg, and 0.6 mg) in bottles containing 100 tablets each, with color-coded labels, and in color- coded Patient Convenience Packages of 4 bottles of 25 tablets each.

0.3 mg (1/200 grain): Coded “N” on one side and “3” on the other.

N 0071-0417-24—Bottle of 100 tablets

0.4 mg (1/150 grain): Coded “N” on one side and “4” on the other.

N 0071-0418-13—Convenience Package
N 0071-0418-24—Bottle of 100 tablets

0.6 mg (1/100 grain): Coded “N” on one side and “6” on the other.

N 0071-0419-24—Bottle of 100 tablets

Store at Controlled Room Temperature 20°-25°C (68°-77°F) [see USP]. Rx only

March 2000. Manufactured by: Parke Davis Pharmaceuticals, Ltd. Vega Baja, PR 00694. Distributed by: PARKE-DAVIS, Division of Warner-Lambert Co Morris Plains, NJ 07950 USA.

Bookmark this page: